VBI Historical Cash Flow

VBIVQ Stock

0.0005 0.0001 16.67%

Analysis of VBI Vaccines cash flow over time is an excellent tool to project VBI Vaccines future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Stock Based Compensation of 8.6 M or Begin Period Cash Flow of 88.6 M as it is a great indicator of VBI Vaccines ability to facilitate future growth, repay debt on time or pay out dividends.

Cash Flow Balance Sheet Income Statement

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in VBI Vaccines. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

To learn how to invest in VBI Stock, please use our How to Invest in VBI Vaccines guide.

About VBI Cash Flow Analysis

The Cash Flow Statement is a financial statement that shows how changes in VBI balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which VBI's non-liquid assets can be easily converted into cash.

VBI Vaccines Cash Flow Chart

At this time, VBI Vaccines' Stock Based Compensation is relatively stable compared to the past year. As of 12/27/2024, Begin Period Cash Flow is likely to grow to about 88.6 M, while Change In Cash is likely to drop (40.9 M).

Stock Based Compensation Begin Period Cash Flow Other Non Cash Items Capital Expenditures

Add Fundamental

Stock Based Compensation

Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.

Capital Expenditures

Capital Expenditures are funds used by VBI Vaccines to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of VBI Vaccines operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.

Most accounts from VBI Vaccines' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into VBI Vaccines current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in VBI Vaccines. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

To learn how to invest in VBI Stock, please use our How to Invest in VBI Vaccines guide.At this time, VBI Vaccines' Stock Based Compensation is relatively stable compared to the past year. As of 12/27/2024, Begin Period Cash Flow is likely to grow to about 88.6 M, while Change In Cash is likely to drop (40.9 M).

	2021	2022	2023	2024 (projected)
Other Non Cash Items	1.9M	360K	475K	630.4K
Depreciation	1.8M	2.1M	2.0M	2.1M

Other Non Cash Items Depreciation

VBI Vaccines cash flow statement Correlations

	Change To Inventory	Investments	Change In Cash	Stock Based Compensation	Free Cash Flow	Change In Working Capital	Begin Period Cash Flow	Depreciation	Other Non Cash Items	Capital Expenditures	Change To Account Receivables	Issuance Of Capital Stock	Net Income	End Period Cash Flow
Change To Inventory		-0.22	0.42	-0.49	0.99	0.2	-0.63	-0.78	0.36	-0.59	0.72	0.66	0.83	0.78
Investments	-0.22		0.79	0.9	-0.34	0.79	0.81	0.76	0.82	0.43	-0.54	-0.87	-0.73	-0.29
Change In Cash	0.42	0.79		0.55	0.3	0.88	0.37	0.21	0.99	0.08	-0.08	-0.4	-0.16	0.25
Stock Based Compensation	-0.49	0.9	0.55		-0.6	0.72	0.98	0.85	0.63	0.7	-0.79	-0.92	-0.86	-0.34
Free Cash Flow	0.99	-0.34	0.3	-0.6		0.07	-0.73	-0.85	0.22	-0.64	0.78	0.75	0.89	0.77
Change In Working Capital	0.2	0.79	0.88	0.72	0.07		0.61	0.29	0.93	0.51	-0.46	-0.52	-0.3	0.34
Begin Period Cash Flow	-0.63	0.81	0.37	0.98	-0.73	0.61		0.87	0.47	0.81	-0.89	-0.92	-0.9	-0.39
Depreciation	-0.78	0.76	0.21	0.85	-0.85	0.29	0.87		0.26	0.53	-0.71	-0.96	-0.99	-0.78
Other Non Cash Items	0.36	0.82	0.99	0.63	0.22	0.93	0.47	0.26		0.18	-0.18	-0.45	-0.22	0.25
Capital Expenditures	-0.59	0.43	0.08	0.7	-0.64	0.51	0.81	0.53	0.18		-0.97	-0.63	-0.63	-0.05
Change To Account Receivables	0.72	-0.54	-0.08	-0.79	0.78	-0.46	-0.89	-0.71	-0.18	-0.97		0.78	0.79	0.27
Issuance Of Capital Stock	0.66	-0.87	-0.4	-0.92	0.75	-0.52	-0.92	-0.96	-0.45	-0.63	0.78		0.96	0.6
Net Income	0.83	-0.73	-0.16	-0.86	0.89	-0.3	-0.9	-0.99	-0.22	-0.63	0.79	0.96		0.74
End Period Cash Flow	0.78	-0.29	0.25	-0.34	0.77	0.34	-0.39	-0.78	0.25	-0.05	0.27	0.6	0.74

Click cells to compare fundamentals

VBI Vaccines Account Relationship Matchups

Pair Trading with VBI Vaccines

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if VBI Vaccines position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in VBI Vaccines will appreciate offsetting losses from the drop in the long position's value.

Moving together with VBI Stock

0.62

EMMA

Emmaus Life Sciences

Pair Corr

Moving against VBI Stock

0.57	EPRX	Eupraxia Pharmaceuticals	Pair Corr
0.45	GRCE	Grace Therapeutics, Symbol Change	Pair Corr
0.45	FBIOP	Fortress Biotech Pref	Pair Corr
0.39	FRTX	Fresh Tracks Therapeutics	Pair Corr
0.34	UPB	Upstream Bio,	Pair Corr

The ability to find closely correlated positions to VBI Vaccines could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace VBI Vaccines when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back VBI Vaccines - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling VBI Vaccines to buy it.

The correlation of VBI Vaccines is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as VBI Vaccines moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if VBI Vaccines moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for VBI Vaccines can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Additional Tools for VBI Stock Analysis

When running VBI Vaccines' price analysis, check to measure VBI Vaccines' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VBI Vaccines is operating at the current time. Most of VBI Vaccines' value examination focuses on studying past and present price action to predict the probability of VBI Vaccines' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VBI Vaccines' price. Additionally, you may evaluate how the addition of VBI Vaccines to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC